SVU - International Journal of Medical Sciences (Jul 2022)

Clinical Audits of Sever pre-eclampsia Management at South Valley University Hospitals

  • Tahany Fathy*,
  • Mahmoud Almolakab B Alrashedy,
  • Mahmoud Iwes,
  • Mohammad AM Ahmed

DOI
https://doi.org/10.21608/svuijm.2022.125060.1290
Journal volume & issue
Vol. 5, no. 2
pp. 200 – 208

Abstract

Read online

Background: Clinical audits based on standard criteria have been used in developed countries to improve the management of certain diseases as pre-eclampsia and eclampsia. It has been introduced nowadays in the assessment of diseases indeveloping countries Objectives: To assess the management of sever pre-eclampsia in South valley university Hospitals. Patients and method(s):This clinical audit was conducted on pregnant women who had sever pre-eclampsia from those admitted to Obstetrics & Gynecology department of South Valley University Hospitals during the period from September 2016 to september2020. Patients were diagnosed as sever preeclampsia according to RCOG criteria 2019. Results: The study was conducted on 150 patient had severe preeclampsia. The results showed 70% of patients were primigravida and old age, 40% of patients received corticosteroid within 7 day before termination, 50% of patients received Magnesium sulphate, 60% of patients were admitted to ICU. 70% of patients were not terminated before 37weeks. Conclusion: Learning doctors about symptoms, signs and complication of sever preeclampsia, patient with sever preeclampsia should be admitted to hospital, do investigation 3 time per week. Measurement of blood pressure (BP) every 15-30 minute until BP less than 160/110 then 4 time / day. Use the suitable antihypertensive drug as labetalol as first line, then nifedipine. Women with sever preeclampsia should admit to ICU. Intravenous sulphate should be taken

Keywords